Skip to main content
TipRanks
Go Ultimate75% OFF

Microvast Holdings (2OZA) Q3 2026 Earnings Report

4 Followers

DE:2OZA Q3 2026 EPS Results

Actual EPS
-EUR 0.18
Consensus EPS
EUR 0.00
Beat/Miss
Missed by -EUR 0.18
One Year Ago EPS
EUR 0.04

DE:2OZA Q3 2026 Revenue Results

Actual Revenue
EUR 41.75M
Expected Revenue
EUR 73.15M
Beat/Miss
Missed by -EUR 31.40M
YoY Revenue Growth
-62.85%

Earnings Announcement Details

Quarter
Q3 2026
Date
11/09/2026
Time
After Close
Conference Call
Monday, November 9, 2026
DE:2OZA Upcoming Earnings

Microvast Holdings's next earnings date is estimated for April 5, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Audio

DE:2OZA Q3 2026 Earnings Call
0:00 / 0:00

Q3 2026 Earnings Slide Deck

Q3 2026 Earnings Call Summary

Q3 2026
Earnings Call Date:Nov 09, 2026|% Change Since:-63.96%|
Earnings Call Sentiment|Negative

The call was materially negative. Management described a highly challenging operating environment, with quarterly revenue down 62.8%, significant sales-volume declines, sharply lower gross margins, substantial impairment charges, negative adjusted EBITDA, negative operating cash flow, and unresolved liquidity and going-concern uncertainty. The company cited completed manufacturing milestones, research and development progress, cost actions, and financing and asset-sale activity, but these positives were outweighed by the financial deterioration and stated risks.

Company Guidance

Management said production ramp up at the Huzhou phase 3.2 line depends on customer demand, production yields, production qualification, operating efficiency, and working capital availability, and that unless production volumes increase significantly, the line will operate below its design capacity; full-scale construction at Clarksville remains contingent upon additional financing and the strategic partnerships. Near term priorities are controlling cost, preserving liquidity, addressing significant near term debt maturity, and stabilizing operations, with operating cost reduction initiatives, reduced and deferred discretionary capital expenditures, and targeted reduction in workforce, although the cost reduction program has not been fully implemented and cash costs associated with it have and may continue to strain near term liquidity. Management is negotiating to refinance, extend, or restructure near-term debt obligations and exploring potential asset sales, with no assurance that those negotiations will be successful, while substantial doubt about the ability to continue as a going concern has not been alleviated. In research and development, the 70 layer bipolar prototype delivered approximately 72 V and achieved a specific energy of 366 watt hour per kilogram, while a long cycle development cell retained over 79.5% of its capacity after more than 1.3 thousand cycles at 0.33 c; these technologies remain under development, and the results are preliminary research and development data, not commercial qualification results.

  • Huzhou Phase 3.2 Equipment CommissionedInstallation and commissioning of the Phase 3.2 production equipment at the Huzhou, China facility were completed. Production ramp-up remains dependent on customer demand, production yields, qualification, operating efficiency, and working capital availability.
  • Clarksville Pack Assembly Line Substantially CompletedThe pack assembly line at the Clarksville, United States facility is substantially completed. Full-scale construction remains contingent upon additional financing and strategic partnerships.
  • Solid-State Battery Prototype ProgressThe electrolyte-free solid-state architecture advanced under laboratory conditions. A 70-layer bipolar prototype delivered approximately 72 volts and achieved specific energy of 366 watt-hours per kilogram. A long-cycle development cell retained over 79.5% of its capacity after more than 1.3 thousand cycles at 0.33C. The company stated that these are preliminary research and development results, not commercial qualification results, and that further validation, repeat testing, scale-up, customer qualification, manufacturing readiness, and capital availability are required.
  • Silicon-Sulfur Chemistry AdvancementEarly laboratory prototypes paired a sulfur-based cathode with a prelithiated silicon-based anode. A five-layer bipolar prototype study showed that cathode expansion was partially offset by anode contraction during discharge, which the company is evaluating as a potential pathway to monolithic integration in higher-voltage solid-state assemblies. The chemistry remains at an early laboratory prototype stage and requires further validation, testing, scale-up, qualification, manufacturing readiness, and capital.
  • Investment in New Product DevelopmentResearch and development expenses increased by $605 thousand, or 78%, year over year in the quarter and by $2.3 million, or 9.7%, for the nine-month period, primarily due to higher labor costs as the company expanded its investment in new product development.
  • Lower Selling and Marketing CostsSelling and marketing expenses decreased by $1.4 million, or 23.9%, in the quarter and by $1.6 million, or 9.7%, for the nine-month period, primarily due to lower personnel costs.
  • Reduced Investing Cash Outflow and Facility Sale ProceedsNet cash used in investing activities was $5.6 million for the nine-month period, compared with $15.5 million in the same period in 2025. The outflow included $9.2 million for a Houston office building, $7.3 million for machinery and equipment and Huzhou Phase 3.2 expansion, partially offset by $10.8 million in proceeds from the sale of the Lake Mary, Florida facility.
  • Improved Credit Management and Higher Financing ProceedsA decrease in accounts receivable was attributed to improved credit management. Net cash generated by financing activities was $23.3 million for the nine-month period, an increase of $32.8 million compared with the $9.5 million used in the same period in 2025, primarily due to a $25.7 million increase in proceeds from bank borrowings.

DE:2OZA Earnings History

DE:2OZA earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Apr 05, 20272026 (Q4)0.01--0.04――
Nov 09, 20262026 (Q3)0.00-0.180.04-600.00% (-0.22)
Aug 10, 20262026 (Q2)-0.00-0.010.05-120.00% (-0.05)
May 11, 20262026 (Q1)0.00-0.040.05-166.67% (-0.09)
Mar 16, 20262025 (Q4)0.02-0.10-0.01-1000.00% (-0.09)
Nov 10, 20252025 (Q3)0.030.040.05-20.00% (-0.01)
Aug 11, 20252025 (Q2)0.010.05-0.19123.81% (+0.24)
May 12, 20252025 (Q1)―0.05-0.04225.00% (+0.08)
Mar 31, 20252024 (Q4)-0.010.05-0.04250.00% (+0.09)
Nov 12, 20242024 (Q3)-0.040.05-0.03266.67% (+0.07)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed